Updates
Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals
Medications for opioid use disorder (MOUD), namely methadone, buprenorphine, or naltrexone, remain the most effective treatment for opioid use disorder (OUD), yet they remain underutilized. This cross-sectional study aimed to describe MOUD availability at psychiatric...
SAMSHA Survey Results: Data on SUD and Mental Health Treatment Facilities
The 2023 National Substance Use and Mental Health Services Survey report is based on data collected from 20,681 treatment facilities across the U.S., including 14,620 facilities for substance use, 9,856 for mental health and 3,795 offering both types of treatment....
New NC Statewide Overdose Surveillance Reports for October 2024
The Injury and Violence Prevention Branch of the Division of Public Health (IVPB) recently posted an update of suspected overdose deaths, fentanyl-positive deaths, and provisional data on Emergency Department (ED) visits for overdose reports. While the year-to-date...
New Data Shows Overdose Deaths are Rising Among Black and Indigenous Americans
The recent decline in overdose deaths hides a tremendous disparity by race: Deaths have fallen only among white people while continuing to rise among people of color, according to a new Stateline analysis of federal data. Health experts in nonwhite communities say...
Eliminate Systemic Inequities for Black Mothers With SUD
Between 2010 and 2017, the U.S. saw a 131% increase in maternal opioid use disorder at delivery. There also was an 83% rise in cases of neonatal abstinence syndrome due to prenatal opioid exposure. Additionally, between 2016 and 2020, there was a 3.6% increase in...
Coming Events
NC Statewide Overdose Reports
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.